RecruitingNCT06430762

Therapeutic Exposures and Risk Factors in MRONJ

Identification of Therapeutic Exposures and Risk Factors Associated With Medication-Related Osteonecrosis of the Jaw


Sponsor

Marmara University

Enrollment

250 participants

Start Date

Apr 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria4

  • Individuals aged 18 and over
  • Male or female individuals
  • Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
  • Individuals or their legal representatives who have given written consent to participate in the study

Exclusion Criteria5

  • Non-drug-related osteonecrosis/osteomyelitis
  • Osteoradionecrosis
  • Metastasis to the oral region
  • Individuals who have not given written consent to participate in the study
  • Individuals under the age of 18

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Marmara University School of Dentistry

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06430762


Related Trials